Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
- PMID: 31576704
- PMCID: PMC6779628
- DOI: 10.3802/jgo.2019.30.e119
Therapeutic vaccination using HPV 16 E7 to eradicate CIN3
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.J Gynecol Oncol. 2019 Nov;30(6):e88. doi: 10.3802/jgo.2019.30.e88. J Gynecol Oncol. 2019. PMID: 31576684 Free PMC article. Clinical Trial.
Similar articles
-
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials.BMJ Open. 2017 Aug 18;7(8):e015867. doi: 10.1136/bmjopen-2017-015867. BMJ Open. 2017. PMID: 28821519 Free PMC article. Clinical Trial.
-
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein-based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia.Cancer Immunol Immunother. 2004 Jul;53(7):642-50. doi: 10.1007/s00262-004-0501-4. Epub 2004 Feb 17. Cancer Immunol Immunother. 2004. PMID: 14985860 Free PMC article. Clinical Trial.
-
Oral vaccination against HPV E7 for treatment of cervical intraepithelial neoplasia grade 3 (CIN3) elicits E7-specific mucosal immunity in the cervix of CIN3 patients.Vaccine. 2014 Oct 29;32(47):6233-9. doi: 10.1016/j.vaccine.2014.09.020. Epub 2014 Sep 22. Vaccine. 2014. PMID: 25258102 Clinical Trial.
-
Cell-mediated immune response: a clinical review of the therapeutic potential of human papillomavirus vaccination.Acta Obstet Gynecol Scand. 2014 Dec;93(12):1209-18. doi: 10.1111/aogs.12480. Epub 2014 Sep 20. Acta Obstet Gynecol Scand. 2014. PMID: 25146484 Review.
-
Human papillomavirus vaccines versus cervical cancer screening.Clin Oncol (R Coll Radiol). 2008 Aug;20(6):388-94. doi: 10.1016/j.clon.2008.04.006. Epub 2008 Jun 5. Clin Oncol (R Coll Radiol). 2008. PMID: 18538554 Review.
Cited by
-
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution's Experience.Vaccines (Basel). 2020 Jan 25;8(1):45. doi: 10.3390/vaccines8010045. Vaccines (Basel). 2020. PMID: 31991753 Free PMC article.
-
Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3.J Gynecol Oncol. 2020 Mar;31(2):e43. doi: 10.3802/jgo.2020.31.e43. J Gynecol Oncol. 2020. PMID: 32100488 Free PMC article. No abstract available.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Karamperopoulos D, Kouzis A. Cancer in ancient Greek physicians. Athens: Stamoulis; 1902.
-
- Rigoni-Stern DA. Statistical facts related to cancerous diseases. G Serv Progress Patologia Terapia. 1842;2:507–517.